Publications (196) Juan Pablo de Torres Tajes publications

filter_list

2026

  1. Lung Diffusing Capacity Improves the Prognostic Validity of the GOLD Spirometric Staging in COPD

    Archivos de Bronconeumologia, Vol. 62, Núm. 1, pp. 20-27

2025

  1. Brief Report: Emphysema as a Prognostic Factor in Patients With Advanced NSCLC With COPD Receiving Immune Checkpoint Inhibitors

    Journal of Thoracic Oncology

  2. Chronic Respiratory Diseases and Lung Cancer Risk

    Archivos de Bronconeumologia

  3. Combining Airway Clearance Techniques and Inhaled Antibiotics in Chronic Bronchial Infection: Real-World Evidence of Exacerbation Reduction (INBREATHING Study)

    Archivos de Bronconeumologia

  4. Exploring the impact of surgical treatment for lung cancer in patients with Airway Obstruction from a Lung Cancer Screening Program

    PLoS ONE, Vol. 20, Núm. 5 May

  5. Female sex and lung cancer risk in two large screening cohorts

    Respiratory Medicine, Vol. 248

  6. Phenotype Analysis of Chronic Bronchial Infection Patients on Inhaled Antibiotic Therapy: A Multicentre Retrospective Cohort Study in Spain (INBREATHING Study)

    Archivos de Bronconeumologia

  7. Sleep-disordered Breathing in Patients with Chronic Obstructive Pulmonary Disease: Prevalence and Outcomes

    Annals of the American Thoracic Society, Vol. 22, Núm. 8, pp. 1227-1235

  8. The Tree That Let Us See the Forest: The Importance of Comorbidities in Lung Cancer Screening Programs

    Journal of Thoracic Oncology

  9. Validation and accuracy of the Hyfe cough monitoring system: a multicenter clinical study

    Scientific Reports, Vol. 15, Núm. 1

2024

  1. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

    Microchemical Journal, Vol. 199

  2. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

  3. Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP

    Archivos de Bronconeumologia, Vol. 60, Núm. 9, pp. 559-564

  4. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100

  5. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

  6. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma

    eBioMedicine, Vol. 102

2023

  1. Continuous Monitoring of Pulse Oximetry During the 6-Minute Walk Test Improves Clinical Outcomes Prediction in COPD

    Respiratory care, Vol. 68, Núm. 1, pp. 92-100

  2. Dynamic Ventilatory Reserve During Incremental Exercise: Reference Values and Clinical Validation in Chronic Obstructive Pulmonary Disease

    Annals of the American Thoracic Society, Vol. 20, Núm. 10, pp. 1425-1434

  3. Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 29, Núm. 10, pp. 1100-1108

  4. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 18